1. Rat hearts were perfused with 32P1, and contractile force was increased by positive inotropic agents (agents that increase contractility). The inhibitory subunit of troponin (troponin I) was then isolated by affinity chromatography in 8M-urea, and its 32P content measured. Incorporation of phosphate into the subunit was calculated on the basis of the [y-32P]ATP specific radioactivity in the hearts. 2. When hearts were perfused with 30nM-DL-isoprenaline (N-isopropylnoradrenaline), there was an increase in contractile force over 30s which was paralleled by an increase in troponin I phosphorylation. When hearts were perfused for 25 s with increasing concentrations of isoprenaline from 1 nm to 0.6pM, there was again a parallel increase in contractile force and troponin I phosphorylation. The maximum phosphorylation observed was 1.5 mol of phosphate/mol of troponin I, which was reached after 25s with 0.1 4uM-isoprenaline. 3. Hearts were stimulated with a 15s pulse perfusion of 30nM-DL-isoprenaline. There was an increase in contractile force which was followed by a return to the control value within 50s. Troponin I phosphorylation increased to a plateau value which was reached within 30s, and remained constant for 60s after the isoprenaline pulse. Phosphorylase a and 3': 5'-cyclic AMP concentration showed changes similar to that ofthe contractile force. There was no change in 3': 5'-cyclic GMP concentration. 4. When hearts stimulated with a l5s pulse of isoprenaline were subsequently perfused with 0.6pM-acetylcholine, the changes in contractile force, phosphorylase a and 3': 5'-cyclic AMP were very similar to those seen with the 15 s pulse of isoprenaline alone. Troponin I phosphorylation increased to a maximum 30s after the end of the isoprenaline pulse, but then rapidly decreased during the subsequent 30s. This decrease was preceded by a 60 % increase in the concentration of 3': 5'-cyclic GMP. 5. Hearts were perfused with 0.2gM-glucagon for periods up to 60s. Contractile force showed little change for the first 30s, but then increased rapidly. This was paralleled by changes in 3': 5'-cyclic AMP concentration. Troponin I phosphorylation increased slowly, but the increase in contractile force had reached a maximum before significant phosphorylation had occurred. 6. It is concluded that under certain conditions, e.g. immediately after ,B-adrenergic stimulation, there is a good correlation between contractile force and troponin I phosphorylation. However, under other conditions, e.g. when contractile force is decreasing after removal off8-adrenergic stimulation or in the presence ofglucagon, contractile force and troponin I phosphorylation are not well correlated. These results suggest that mechanisms for modifying cardiac contractility, other than troponin I phosphorylation, must be present in rat heart.
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The increase in contractility which occurs in heart muscle in response to adrenergic stimulation is now thought to be mediated via changes in the concentration of 3': 5'-cyclic AMP (Sutherland et al., 1968; Sobel & Mayer, 1973; Kukovetz etal., 1975; Osnes & 0ye, 1975) . However, the intracellular mode of action of 3': 5'-cyclic AMP in this response is not understood. Two hypotheses involving modification of proteins by phosphorylation have been proposed. One involves the phosphorylation of sarcoplasmic reticulum or sarcolemma (reviewed in Katz et al., 1975; Krause etal., 1975) , leading to changes in intracellular C2+ distribution and subsequent changes in contractility. The second hypothesis involves phosphorylation of contractile proteins, in particular troponin (Stull et al., 1972; England et al., 1973) .
Troponin is composed of three subunits, a Ca2+-binding subunit (troponin C), an inhibitory subunit (troponin I) and a tropomyosin-binding subunit (troponin T). Both troponin I and troponin T have been shown to be phosphorylated in vitro by phosphorylase kinase and 3':5'-cyclic AMP-dependent protein kinase in skeletal muscle (Bailey & VillarPalasi, 1971; Stull et al., 1972; England et al., 1973;  Vol. 160 Perry & Cole, 1973) and cardiac muscle (Reddy et al., 1973; Cole & Perry, 1975; Rubio et al., 1975) . Cole & Perry (1975) have shown, however, that with whole troponin as substrate, the highest rate ofphosphorylation was with cardiactroponin and cardiac 3': 5'-cyclic AMP-dependent protein kinase. Under these conditions only troponin I was phosphorylated, and this suggests that troponin phosphorylation is likely to be of more physiological significance in cardiac muscle.
The hypothesis as proposed by Stull et al. (1972) and England eta!. (1973) suggested that phosphorylation of troponin could modify its properties to allow an increased interaction of the contractile elements. This could be attained either by a decrease in the inhibitory properties of troponin, or by changing its Ca2+ sensitivity. The finding of Rubio et al. (1975) that phosphorylation of troponin in guinea-pig cardiac native actomyosin caused a lowering of the Ca2+ concentration required to activate actomyosin adenosine triphosphatase gave support to this hypothesis. Experiments showing that phosphorylation of troponin I occurred in intact perfused rat heart on stimulation with adrenaline (England, 1975) provided additional evidence. These results showed that there was a time-dependent increase in contractile force, and that these parallel increases in phosphorylation and contractile force resulted from stimulation at various concentrations of adrenaline. The present work extended the results obtained with adrenaline by using other agents that change the contractility of the perfused rat heart, and by measuring the state of phosphorylation of troponin I. By choosing a variety of conditions and performing detailed time-course analyses of the responses, it was hoped that these experiments would provide a rigorous test in vivo of the hypothesis that changes in troponin I phosphorylation are closely associated with changes in cardiac contractility. Materials and Methods Heart perfusions These were carried out as previously described (England, 1975) . Briefly, hearts from male Wistar rats (300-400g) were removed under barbiturateinduced anaesthesia and perfused by the Langendorff technique at constant pressure (6kPa) with bicarbonate-buffered medium (Krebs & Henseleit, 1932) containing 11 mM-glucose but with the Pi concentration lowered to 0.234mm to increase the 32P, specific radioactivity (England & Walsh, 1976) . After 5min ofpre-perfusion, to allow recovery after removal from the animal, the hearts were perfused with medium containing approx. lO,Ci of 32PI/ml for 15min in a recirculating system. The purpose of the perfusion with 32P, was to permit incorporation of 32p into intracellular ATP (y position) (England & Walsh, 1976) , which was then assumed to be the phosphate donor to troponin I during phosphorylation. The validity of this assumption is discussed in the Results and Discussion sections. After this the hearts were given a 1 min perfusion by drip-through with nonradioactive medium. Substances modifying the contractile response were then administered at constant concentrations by continuation of the drip-through perfusions. Contractile force at the peak ofthe lengthtension curve was monitored with a force-displacement transducer (Devices Instruments Ltd., Welwyn Garden City, Herts., U.K.) attached by thread to the apex of the heart. For measurements of cyclic nucleotide concentrations, hearts were perfused as above but omitting 32P, from the medium. Contractile force and phosphorylase a were measured in these hearts to confirm the similarity of response to those perfused with 32P1. At the end of the perfusions the hearts were rapidly frozen (Wollenberger et al., 1960) and powdered under liquid N2.
Analytical methods
The concentration of ATP in neutralized HC104 extracts of hearts was measured as described by Lamprecht & Trautschold (1963) with hexokinase and glucose 6-phosphate dehydrogenase, and gave values of 16-22,umol/g of dry heart in control perfusions. In a small number of hearts (less than 5 %) the ATP concentration was less than 16pmol/g, and the results obtained with these hearts were ignored.
[y-32P]ATP specific radioactivity in heart extracts was measured by incorporation of 32P into phosphorylase as previously described (England, 1975; England & Walsh, 1976) .
The concentration of 3': 5'-cyclic AMP and 3': 5'-cyclic GMP were measured in heart extracts prepared by deproteinization with 0.6M-trichloroacetic acid, followed by removal of the acid with water-saturated diethyl ether. 3': 5'-Cyclic AMP was assayed by the protein-binding displacement assay of Brown et al. (1971) . 3':5'-Cyclic GMP assays were kindly performed by Dr. Janet Albano, Department of Pharmacology, University of Bristol. This method used a specific antibody for 3': 5'-cyclic GMP, separation of bound and free 3': 5'-cyclic GMP being achieved by Millipore-membrane (0.45 um pore size) filtration. The material that assayed as 3': 5'-cyclic GMP in heart extracts could be destroyed on treatment with phosphodiesterase, and the amount assayed was linearly related to the amount of extract used.
The proportions of phosphorylase in a and b forms was measured essentially as described by Stull & Mayer (1971) . A small amount (30-40mg) of frozen heart powder was homogenized in 1 ml of 60% (v/v) glycerol/20mM-NaF/1 mM-EDTA, pH 7.5, at -40'C. The extract was gradually allowed to thaw during homogenization, 1 ml of 20mM-fl-glycerol phosphate, pH6.8, was then added, and the extract centrifuged 1.00 Mobility relative to Bromophenol Blue Fig. 1 . Distribution ofprotein and radioactivity, after polyacrylamide-gelelectrophoresis with sodiwm dodecylsulphate, in troponin Ipurified by affinity chromatography Troponin I was purified from rat heart perfused with 32p1 by affinity chromatography as described in the text. Electrophoresis in 10% polyacrylamide gels in the presence of 0.1% sodium dodecyl sulphate was carried out as described by Weber & Osborn (1969) , with 20,ug of troponin I per gel. After electrophoresis the gel was stained with Coomassie Brilliant Blue, and the E600 measured by using a Gilford linear transport system attached to a spectrophotometer (a). The gel was subsequently sliced into 3mm transverse sections which were dissolved in 30% (w/v) H202 and counted by liquid-scintillation spectrometry (b) as described by Tishler & Epstein (1968) . The molecular weight of the protein was determined as described by Weber & Osbom (1969) , using as standard proteins: phosphorylase b, pyruvate kinase, lactate dehydrogenase and cytochrome c.
presence and absence of 2mM-AMP in the supernatant was assayed as described by Hardman et al. (1965) . The production of glucose 1-phosphate from glycogen in the presence of 50mM-Pi was measured by a coupled fluorimetric system with phosphoglucomutase and glucose 6-phosphate dehydrogenase. The proportion of phosphorylase a in the extracts was calculated as the ratio of activities without and with AMP divided by 0.7 (0.7 is the ratio of activities of pure phosphorylase a without and with AMP).
Troponin I was isolated, with a purity exceeding 96 % as measured by polyacrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate, by the affinity-chromatography method of Syska et al. (1974) . Details of the method as applied to rat Vol. 160 heart extracts are given in England (1975) . Fig. 1 shows a typical absorbance profile of purified troponin I after polyacrylamide-gel electrophoresis, and also the distribution of 32p in the gel. There was essentially one protein band only, and all the radioactivity migrated with this band. The yield of troponin I was approx. 0.3 mg/g of wet heart, and was independent of the extent of phosphorylation. This indicated that the affinity chromatography was not purifying a particular phosphorylation state of troponin I.
During the purification of phosphorylated proteins, a major problem is to ensure that dephosphorylation or additional phosphorylation does not occur by enzymic or chemical action. The affinity-chromatography procedure for isolation of troponin I was carried out in the presence of 8 M-urea, which was only removed at the final stage when the troponin I was pure. The possibility of enzymic modification of the phosphorylation state of troponin I during this procedure was therefore minimized. However, experiments were performed that directly tested the efficiency of 8 M-urea in preventing protein modification. Cardiac troponin was isolated [bya modification of the method of Greaser & Gergely (1971)] and phosphorylated in troponin I by cardiac 3': 5'-cyclic AMP-dependent protein kinase and [y-32P]ATP (Ray & England, 1976b) . The 32P-labelled troponin was then mixed with non-radioactive perfused heart powder, and troponin I was isolated by affinity chromatography. More than 85% of the added 32P was recovered in the troponin I fraction, showing that little or no dephosphorylation had occurred during isolation. The small loss of radioactivity that occurred was probably caused by incomplete binding of troponin I to the affinity column, rather than dephosphorylation. In a second experiment, [y_32p]_ ATP was added to a non-radioactive perfused heart powder, and troponin I isolated. No radioactivity was associated with the troponin I, showing that no additional phosphorylation occurred during isolation. The 32P present in troponin I was converted into mol of phosphate by using the [y-32P]ATP specific radioactivity as previously described (England, 1975) .
Materials
Phosphorylase b was prepared as described by Fischer & Krebs (1958) , and phosphorylase kinase as described by Cohen (1973) . 3': 5'-Cyclic AMPdependent protein kinase from ox heart muscle was prepared up to the DEAE-cellulose-column-chromatography step as described by Reimann et al. (1971) for the skeletal-muscle enzyme. [y-32P]ATPwas prepared by the method of Glynn & Chappell (1964 In a previous study (England, 1975) , contractile force and troponin I phosphorylation were measured in perfused rat hearts stimulated with adrenaline. A maximum incorporation of approx. 1 mol of phosphate/mol of troponin I was obtained. Cole & Perry (1975) , however, reported that 2mol of phosphate/ mol of troponin I could be incorporated into bovine cardiac troponin by incubation in vitro with 3': 5'-cyclic AMP-dependent protein kinase. In view of the lower phosphorylation obtained in rat hearts perfused with adrenaline, an attempt was made to incorporate additional phosphate into troponin I in the perfused heart. Isoprenaline is a very potent f8-adrenergic agonist (Goodman & Gilman, 1970) , and was used in the perfusion system in an attempt to increase troponin I phosphorylation above that obtained with adrenaline. In addition, isoprenaline has little a-adrenergic activity (Goodman & Gilman, 1970) , and the use of this agent would also indicate whether the phosphorylation of troponin I was mediated solely via the ,B-adrenergic receptor. Fig. 2 shows the time-course of changes in contractile force and troponin I phosphorylation in hearts perfused with 30nnM-DL-isoprenaline. After a short lag period contractile force increased to approx. 170% of the control value, reaching a plateau after 25-30 s. The control value for troponin I phosphorylation was initially low (approx. 0.2mol of phosphate/ mol of troponin I) but increased to a plateau value of 1.1 mol/mol over a time-course that was very similar to the increase in contractile force. This time-course, and the parallel changes in contractile force and phosphorylation, were very similar to those seen with adrenaline (England, 1975) . Fig. 3 shows a dose-response curve for hearts perfused with concentrations of DL-isoprenaline from 1 nM to 30gM. Hearts were perfused for 25 s with the agonist before being freeze-clamped. There was a linear increase in contractile force with increasing Increase in contractile force (%) Fig. 4 . Correlation between increase in contractileforce and incorporation of 32p into troponin I in perfused rat hearts The data were taken from Figs. 2 and 3 (a) , where the hearts were perfused with DL-isoprenaline, or from England (1975) (o) , where the hearts were perfused with adrenaline.
isoprenaline concentrations from I nM to 0.1 ,m but no further increase occurred at higher concentrations. The phosphorylation of troponin I also showed a similar response, although a certain amount of variability was seen. The maximum phosphorylation found was 1.5mol of phosphate/mol of troponin I, which was considerably higher than that found with adrenaline stimulation (England, 1975) . This result shows that more than one site on troponin I can be phosphorylated in vivo, as was found in vitro by Cole & Perry (1975) . The significance of this additional phosphorylation is discussed below.
The phosphorylation of troponin I described above was estimated on the basis of 32P incorporation, with the assumption that the phosphate donor was [y-32P] (Itaya & Ui, 1966) after alkaline hydrolysis (Meisler & Langan, 1969) as previously described (England, 1975) . In no case did the estimate of total phosphate differ by more than 20% from that calculated by 32P incorporation. Vol. 160 This result agreed with that found in the series of hearts perfused with adrenaline (England, 1975) , and showed the validity of using 32p to measure total phosphate incorporation. Fig. 4 is a replot ofthe data of Figs. 2 and 3, with the percentage increase in contractile force, plotted against troponin I phosphorylation. The data from the study with adrenaline (England, 1975) are also included for comparison. The data obtained by using isoprenaline as the positive inotropic agonist (i.e. the agent causing an increase in contractility) were very similar to those with adrenaline. This suggests that the same (or very similar) mechanism, i.e. interaction of the agonist with the cardiac fi-adrenergic receptor, was mediating the response to both adrenaline and isoprenaline. Fig. 4 shows that the plot of increase in contractile force against troponin I phosphorylation appeared biphasic. Where the amount of phosphate in troponin I was less than 1.0mol/mol there was linear correlation between increase in contractile force and troponin I phosphorylation. Above this value, increased phosphorylation was not accompanied by increased contraction. The significance of this biphasic plot is not clear at present, but it may indicate similarities with other phosphorylated proteins in which more than one phosphorylation site is present. Cohen and co-workers have demonstrated that both phosphorylase kinase and glycogen synthetase can be phosphorylated at multiple sites (Cohen & Antoniw, 1973; Nimmo & Cohen, 1974; Cohen et al., 1975) . With phosphorylase kinase, the enzyme activity was controlled by phosphorylation of one site, and the dephosphorylation of this site was controlled by the phosphorylation state of the other. Phosphorylation of the two sites in glycogen synthetase had synergistic effects on enzyme activity. It is possible that the phosphorylation of troponin I in perfused rat heart may show similar features to these enzyme systems. If it is assumed that phosphorylation of one site only in troponin I is necessary to change cardiac contractility, and that the phosphorylation of a second site has another (at present unknown) function, the curve of Fig. 4 can be explained. However, before this hypothesis can be accepted, it will be necessary to show that phosphorylation of the first site changes the properties of troponin in such a way as to be consistent with changes in cardiac contractility. In addition it must be shown that during the initial part of the curve of Fig. 4 , only one site in troponin I is being phosphorylated, and that partial phosphorylation at two sites does not occur.
Pulse perfusions with isoprenaline
The data above, and that previously published (England, 1975) , showed a good correlation between troponin I phosphorylation and an increase in contraction during the period immediately after stimulation with the agonists, when increases in both contractile force and phosphorylation were occurring. In the experiments described in this section, an attempt was made to study the dephosphorylation of troponin I, after prior stimulation, when contractile force was decreasing. A 15s pulse of a submaximal dose (30 nM) of isoprenaline caused a 60 % increase in force within 30s of the introduction of the agonist, followed by a decrease to the control value after a further 40s (Fig. Sa) . However, the phosphorylation oftroponin I reached a maximum of 0.8 mol of phosphate/mol of troponin I and remained elevated even after contractile force had decreased to the control value. These data showed a lack of correlation between troponin I phosphorylation and force of contraction, indicating that the state of phosphorylation of troponin I was not the only determinant of cardiac contraction, at least under conditions where it was decreasing.
To investigate this result further, the concentrations of 3': 5'-cyclic AMP and 3':5'-cyclic GMP were measured, and also the proportion of phosphorylase in the phosphorylated (a) form (Fig. 5b ). 3': 5'-Cyclic AMP concentration reached a peak rapidly, before the maximum response of the other measured variables. This suggested that increases in 3': 5'-cyclic AMP could be an initial event in response to isoprenaline, and agreed with the hypothesis that increases in the contractility of the heart are mediated by changes in 3':5'-cyclic AMP (Sobel & Mayer, 1973) . The proportion of phosphorylase in the active form increased rapidly, reached a peak value 25s after the start of the isoprenaline perfusion, and then decreased to a value significantly above the control value. This decrease occurred at the same time as troponin I phosphorylation was reaching a maximum, and suggested that the phosphatase catalysing the 1976 dephosphorylation of phosphorylase a was not active towards phosphorylated troponin I. This result was noteworthy in that in skeletal muscle there appeared to be phosphatases with activity towards troponin I which did not remove phosphate from phosphorylase a (Ray & England, 1976a) , and similar enzymes could also be present in heart.
In an attempt to cause dephosphorylation of troponin I, perfused hearts were first stimulated with a 15s pulse of 30nM-isoprenaline, followed by a continuous perfusion with 0.6puM-acetylcholine. Preliminary experiments indicated that this concentration of acetylcholine caused a 15-20% lowering of the rate of beating in control hearts, and this slowing was also seen in the hearts perfused with acetylcholine after a pulse of isoprenaline (Fig. 6) . Fig. 6(a) shows that the response of the contractile force was the same as that in the absence of acetylcholine (Fig. 5a ), but that after approx. 30s with acetylcholine there was a dephosphorylation of troponin I. Even under these conditions, however, there was a decrease in contractile force which occurred before the dephosphorylation of troponin I. Fig. 6 (b) shows that acetylcholine had little effect on the time-course or extent of the changes of 3': 5'-cyclic AMP or phosphorylase a observed after a pulse of isoprenaline (cf. Fig. 5 ), but acetylcholine caused an elevation of the 3': 5'-cyclic GMP concentration after approx. 20s. This increase preceded by 10-20s the dephosphorylation of troponin I. Similar effects of acetylcholine on heart rate, force of contraction and concentrations of 3': 5'-cyclicGMPhavebeennoted inunpacedhearts (George et al., 1973) . It is not possible to conclude from these data that the increase in 3': 5'-cyclic GMP is the direct stimulus for troponin I dephosphorylation, but it has been reported that certain phosphoprotein phosphatases are inhibited by 3':5'-cyclic AMP via a phosphorylation mechanism (Huang & Glinsman, 1975) . It is therefore possible that the dephosphorylation of troponin I in these experiments was caused by stimulation (by an unknown mechanism) of a phosphatase by 3': 5'-cyclic GMP, but experiments with isolated phosphatase preparations will be necessary to substantiate this.
Interpretation of these experiments was partially complicated by the decrease in heart rate seen with acetylcholine, and it is possible that the changes in troponin I phosphorylation caused by this agent were secondary to this effect. To resolve this, it will be necessary to repeat these experiments under conditions where heart rate is kept constant by periodic electrical stimulation. However, George et al. (1973) showed that in rat heart changes in 3': 5'-cyclic GMP and contractile force with acetylcholine were obtained whether or not the heart rate was kept constant. This complication did not arise during perfusions with positive inotropic agents, as little or no increase in heart rate occurred. Vol. 160
Perfusions with glucagon Although the major physiological site of action of glucagon is probably the liver, it has been known for some time that glucagon will increase the contractility of cardiac muscle (Farah & Tuttle, 1960) . This effect required greater concentrations of glucagon than normally found in the mammalian circulation. The increase in contraction was accompanied by increases in 3':5'-cyclic AMP and phosphorylase a, but these were not prevented by the fi-adrenergic blocking agent propranolol (Lucchesi, 1968; Mayer et al., 1970) . These results were interpreted as indicating that glucagon was activating adenylate cyclase, but via a receptor different from that of catecholamines (Mayer et al., 1970) . The time-course of these changes with glucagon was also slower than that seen with adrenaline. Because of these differences, troponin I phosphorylation in perfused rat heart was investigated during stimulation with 0.2,cM-glucagon (Fig. 7) . There was a slight increase in contraction during the first 30s, but a rapid increase then occurred to reach a value of 160% of the control after 40s. ( Fig. 7b ) was very similar, with a slight increase during the first 30s with glucagon, followed by a rapid larger increase. The time-course of troponin I phosphorylation was quite different'from this (Fig. 7a ). There was a slow continuous'rise in phosphorylation which was still increasing after 60 s, and the marked increase in contraction that occurred between 30 and 40s was not accompanied by any comparable increase in phosphorylation. When hearts were stimulated with adrenaline or isoprenaline, increased contraction was always accompanied by increased troponin I phosphorylation. Fig. 4 shows that with either of these agonists an increase in contraction of 60% was accompanied' by phosphorylation of troponin I to a value of 0.7-0.8mol of phosphate/mol of troponin I. During the glucagon perfusions, however, a 60% increase in contraction occurred when the troponin I contained only 0.3-0.4mol of phosphate/mol. The time-course of troponin I phosphorylation was very similar to that seen for phosphorylase intertonversion (Fig. 7b) . However, these data should not be interpreted as suggesting a role for phosphorylase kinase in troponin I'phosphorylation in perfused rat heart. Although Stull et al. (1972) and England et al. (1973) reported a rapid phosphorylation of skeletal-muscle troponin I by phosphorylase kinase, work by Cole & Perry (1975) has shown that cardiac troponin is a much better substrate for 3': 5'-cyclic AMPdependent protein kinase.
General discussion
The initial purpose of the experiments described in this paper was to show whether increases in contractile force were always accompanied by increased troponin I phosphorylation in perfused rat heart, and whether the extent ofphosphorylation was related to the force of contraction. The experiments showed that with adrenaline, isoprenaline and glucagon, troponin I phosphorylation was increased when contractile force was increased. However, study of the time-courses of these changes showed certain discrepancies. In particular, with glucagon perfusion the increase in contractile force preceded a significant increase in phosphorylation. Also, the experiments using pulse perfusions with isoprenaline showed that when contractile force was decreasing after. previous stimulation, there was no corresponding fall in troponin I phosphorylation. There were thus two distinct situations in which troponin I phosphorylation was not correlated with contractile force. The hypothesis outlined in the introduction suggested'that phosphorylation of troponin I caused an increase in Ca2+ sensitivity of the actomyosin system, and that this resulted in increased contractile force without the necessity for changes in intracellular Ca2+ (Stull et al., 1972; England et al., 1973 It is unlikely, however, that the phosphorylation of troponin I has no role in modulation of contraction. The maximum rate of phosphorylation seen in the perfused rat heart was equivalent to 30nmol of phosphate transferred/min per g wet wt. ofheart. The total 3': 5'-cyclic AMP-dependent protein kinase in rat heart is approx. 0.1 unit/g wet wt.
(1 unit is equivalent to 1 ,umol of phosphate transferred/min) with histone as substrate at 37°C (J. D. Corben & S. Keely, personal communication). Cardiac troponin I (as native tropomyosin) is phosphorylated at approx. 35 % of the rate of histone (K. P. Ray & P. J. England, unpublished work). These calculations show that a large proportion of the total protein kinase activity will be required to phosphorylate troponin I during the initial response to Ii-adrenergic agonists (Figs. 2, 5 and 6, and England, 1975) . This calculation assumes that 3': 5'-cyclic AMP-dependent protein kinase is the enzyme actually phosphorylating troponin I in vivo, and that the extracted activity is the total present in the tissue. Although the results in perfused rat heart show that control ofcontraction cannot be exclusively mediated by troponin I phosphorylation, the fact that troponin I is a major phosphorylated protein in heart suggests a role for this effect. The observation of Rubio et al. (1975) that phosphorylation oftroponin I in guinea-pig cardiacactomyosin increased the adenosine triphosphatase sensitivity to Ca2+ also supports this conclusion. However, results in this laboratory (Ray & England, 1976b) have indicated that phosphorylation of troponin I causes a decrease in Ca2+ sensitivity of the actomyosin adenosine triphosphatase from ox and rat cardiac muscle. The discrepancy between these observations and those of Rubio et al. (1975) is difficult to explain, although there could te species differences. These results are difficult to fit into the hypothesis for explaining increased cardiac contrctility through troponin I phosphorylation. Taken in addition to the findings in perfused heart, they throw considerable doubt on a direct action of troponin I phosphorylation in mediating the changes in contractility.
As phosphorylation of troponin I cannot explai changes of contraction in heart, it is necessary to consider other mechanisms for the action of positive inotropic agents. 3':5'-Cyclic AMP has been firmly implicated in this effect (Sobel & Mayer, 1973) , and as many actions of 3':5'-cyclic AMP are mediated through protein phosphorylation (Rubin & Rosen, 1975) , the phosphorylation of other proteins of the excitation-contraction system will be briefly discussed. As was mentioned in the introduction, phosphorylation of cardiac sarcoplasmic reticulum in vitro by 3': 5'-cyclic AMP-dependent protein 1976 kinase, leading to increased Ca2+ uptake, has been known for some time (Kirchberger et al., 1972; Tada et al., 1974; Katz et al., 1975) . Although the significance in vivo of these findings is as yet unclear, it has been proposed (Tada et al., 1974) that the increased Ca2+ uptake leads to increased contractility by abbreviation of systole. Phosphorylation of sarcolemma vesicles from skeletal and cardiac muscle also caused an increased Ca2+ uptake Sulakhe & Drummond, 1974; Krause et al., 1975) . There are thus two potential mechanisms that could alter Ca2+ distribution in cardiac muscle, leading to changes in contractility.
The contractile system itself could also be modified by phosphorylation of proteins other than troponin I. Troponin T as isolated from skeletal muscle contained endogenous phosphate, and was also phosphorylated in vitro (Stull et al., 1972; Pratje & Heilmeyer, 1972; England et at., 1973; Perry & Cole, 1974) . Incubation of cardiac troponin with protein kinase did not cause phosphorylation of troponin T (Cole & Perry, 1975) , and the possible role oftroponin T phosphorylation in the changes in contractility is uncertain. One ofthe light chains ofmyosin in skeletal and cardiac muscle has also been shown to be phosphorylated by a specific kinase (Perrie et al., 1973; Pires et al., 1974; Frearson & Perry, 1975) . Phosphorylation of myosin light chains in platelets caused an increase in actomyosin adenosine triphosphatase activity (Adelstein & Conti, 1975) , although this has not been reported for muscle. This phosphorylation represents another possible mechanism whereby contraction could be modified, although as the lightchain kinase is activated by Ca2+ and not by 3': 5'-cyclic AMP (Pires et al., 1974 ) modification of Ca2+ concentration as discussed above would first be necessary. Therefore there are several potential mechanisms whereby cardiac contractility could be modulated by protein phosphorylation in response to increased 3': 5'-cyclic AMP concentration, of which troponin I phosphorylation is but one.
